FCM
AVNS

Fourpath Capital Management’s Avanos Medical AVNS Stock Holding History

Fourpath Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-510
Closed -$12.3K – 268
2024
Q3 		$12.3K Buy
+510
New +$11.7K ﹤0.01% 479

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Fourpath Capital Management's AVNS Position: Q4 2024 in Review

Fourpath Capital Management sold out of Avanos Medical (AVNS) in Q4 2024, closing a stake of 510 shares — an estimated $12.3K sold.

Fourpath Capital Management first reported a position in AVNS in Q3 2024 and held it in 1 quarter. The position peaked at $12.3K in Q3 2024. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

  • Fourpath Capital Management reported no remaining Avanos Medical position as of Q4 2024 after selling out during the quarter.
  • Fourpath Capital Management sold 510 Avanos Medical shares in Q4 2024, an estimated $12.3K.
  • Fourpath Capital Management first reported a position in Avanos Medical in Q3 2024 and held it in 1 quarter.
  • Fourpath Capital Management's Avanos Medical position peaked at $12.3K in Q3 2024.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on Fourpath Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.